Skip to main content
Explore URMC



Majed A. Refaai, M.D.


Contact Information

Phone Numbers

Office: (585) 276-3927

Fax: (585) 273-3003

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments


Dr. Refaai's clinical service is in Transfusion Medicine with subspecialty involvement in laboratory coagulation/thrombosis testing.


Dr. Refaai's recent studies have included: The in-vitro effect of ABO anti-bodies on platelet function; The correlation between cancer and tissue factor (TF) plasma concentrations and its role in developing DVT; The relationship between the circulating TF and the cancer tissue concentrations of TF in different types of mouse models; Beriplex phase IIIb drug study for bleeding patients with Warfarin overdose; Beriplex phase IIIb drug study for surgical patients who require a quick reversal of Warfarin; The effect of ABO non-identical blood products transfusion on platelet function (in-vivo); Platelet transfusion in patients with positive heparin-induced thrombocytopenia; Comparison of tissue factor pathway inhibitor (TFPI) concentration and activity in mononuclear cells from normal individuals versus patients with Paroxysmal Nocturnal Hemoglobinuria; Comparison of TFPI concentrations in normal mouse plasma and endothelial cells versus a diabetic mouse model; Analysis of fatty acid ethyl ester (FAEE) concentrations in binge drinking, chronic alcoholics, and postmortem biopsies.



  • Clinical Pathology/Laboratory Medicine - American Board of Pathology


MD | Syria - Aleppo Univ School of Medicine, Aleppo

Post-doctoral Training & Residency

07/01/2006 - 06/30/2007
Fellowship in Tranfusion Medicine at University of Texas Southwestern

06/30/2003 - 06/30/2006
Residency in Pathology at Barnes-Jewish Hospitals

04/01/1997 - 05/31/2003
Research in at Massachusetts General Hospital

VIEW ALL expand_more


Journal Articles

Blumberg N, Heal JM, Masel D, Refaai MA. "The precautionary principle and use of Group A plasma in recipients of unknown ABO blood group." Transfusion.. 2018 Mar 0; 58(3):829-831.

Blumberg N, Cholette JM, Pietropaoli AP, Phipps R, Spinelli SL, Eaton MP, Noronha SA, Seghatchian J, Heal JM, Refaai MA. "0.9% NaCl (Normal Saline) - Perhaps not so normal after all?" Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.. 2018 Feb 21; Epub 2018 Feb 21.

Schmidt AE, Gore E, Henrichs KF, Conley G, Dorsey C, Bjugstad KB, Refaai MA, Blumberg N, Cholette JM. "Oxidation Reduction Potential (ORP) is Predictive of Complications Following Pediatric Cardiac Surgery." Pediatric cardiology.. 2018 Feb 0; 39(2):299-306. Epub 2017 Oct 31.